Epithalon is a lab-made peptide built to copy something your body already produces
The primary outcome was a composite of gallbladder or biliary diseases, including gallbladder disorders and biliary related events
Improves how the body handles fat and sugar
How Retatrutide Compares to Other GLP-1 Research Peptides Retatrutide (LY3437943) is a triple agonist that acts on the GLP-1, GIP, and glucagon receptors one more pathway than tirzepatide (GLP-1/GIP) and two more than semaglutide (GLP-1 only)
BPC-157 is typically framed as the more targeted, tissue-specific option in recovery research, while TB-500 is more often positioned as the broader systemic option tied to cell migration, tissue remodeling, and recovery support
Brandon bravely battled cancer for more than three years